Organovo Holdings Inc
NASDAQ:VIVS

Watchlist Manager
Organovo Holdings Inc Logo
Organovo Holdings Inc
NASDAQ:VIVS
Watchlist
Price: 1.93 USD 2.66% Market Closed
Market Cap: 5m USD

Net Margin
Organovo Holdings Inc

-10 151.6%
Current
-6 115%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-10 151.6%
=
Net Income
-12.4m
/
Revenue
122k

Net Margin Across Competitors

No Stocks Found

Organovo Holdings Inc
Glance View

Market Cap
5m USD
Industry
Biotechnology

Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. The company is headquartered in San Diego, California and currently employs 7 full-time employees. The company went IPO on 2013-08-02. The firm is focused on building high fidelity, three-dimensional (3D) tissues that recapitulate key aspects of human disease. The firm is targeting the intestine and has ongoing 3D tissue developments in Ulcerative colitis (UC) and Crohn's disease (CD). The firm uses its platform technology to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function and disease. Its NovoGen Bioprinters are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells. NovoGen Bioprinters can dispense pure hydrogel formulations and also serve as important components of company's tissue prototyping and manufacturing platform. The firm also intends to use its bioprinting platform as well as 3D technologies to treat its target diseases.

VIVS Intrinsic Value
0.94 USD
Overvaluation 51%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-10 151.6%
=
Net Income
-12.4m
/
Revenue
122k
What is the Net Margin of Organovo Holdings Inc?

Based on Organovo Holdings Inc's most recent financial statements, the company has Net Margin of -10 151.6%.

Back to Top